Third Harmonic Bio Inc. (THRD)
Third Harmonic Bio Statistics
Share Statistics
Third Harmonic Bio has 45.11M shares outstanding. The number of shares has increased by 10.15% in one year.
| Shares Outstanding | 45.11M |
| Shares Change (YoY) | 10.15% |
| Shares Change (QoQ) | 0.1% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | 21.26M |
| Failed to Deliver (FTD) Shares | 3 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 1.72M, so 3.8% of the outstanding shares have been sold short.
| Short Interest | 1.72M |
| Short % of Shares Out | 3.8% |
| Short % of Float | 7.6% |
| Short Ratio (days to cover) | 1.02 |
Valuation Ratios
The PE ratio is 9.44 and the forward PE ratio is -4.79. Third Harmonic Bio's PEG ratio is -0.04.
| PE Ratio | 9.44 |
| Forward PE | -4.79 |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 1.51 |
| P/FCF Ratio | -12.44 |
| PEG Ratio | -0.04 |
Enterprise Valuation
Third Harmonic Bio has an Enterprise Value (EV) of 147.55M.
| EV / Sales | 0 |
| EV / EBITDA | 2.51 |
| EV / EBIT | -4.28 |
| EV / FCF | -4.28 |
Financial Position
The company has a current ratio of 40.87, with a Debt / Equity ratio of 0.01.
| Current Ratio | 40.87 |
| Quick Ratio | 40.87 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.05 |
| Debt / FCF | -0.09 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 15.95% and Return on Invested Capital is 20.42%.
| Return on Equity | 15.95% |
| Return on Assets | 15.43% |
| Return on Invested Capital | 20.42% |
| Revenue Per Employee | $0 |
| Profits Per Employee | $857.91K |
| Employee Count | 53 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -55.57% in the last 52 weeks. The beta is 2.51, so Third Harmonic Bio's price volatility has been higher than the market average.
| Beta | 2.51 |
| 52-Week Price Change | -55.57% |
| 50-Day Moving Average | 3.93 |
| 200-Day Moving Average | 9.28 |
| Relative Strength Index (RSI) | 78.89 |
| Average Volume (20 Days) | 902.66K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | 58.87M |
| Net Income | 45.47M |
| EBITDA | 58.87M |
| EBIT | n/a |
| Earnings Per Share (EPS) | 1.09 |
Balance Sheet
The company has 285.06M in cash and 3.21M in debt, giving a net cash position of 281.86M.
| Cash & Cash Equivalents | 285.06M |
| Total Debt | 3.21M |
| Net Cash | 281.86M |
| Retained Earnings | -159.69M |
| Total Assets | 294.61M |
| Working Capital | 283.43M |
Cash Flow
In the last 12 months, operating cash flow was -34.5M and capital expenditures -10K, giving a free cash flow of -34.51M.
| Operating Cash Flow | -34.5M |
| Capital Expenditures | -10K |
| Free Cash Flow | -34.51M |
| FCF Per Share | -0.83 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
THRD pays an annual dividend of $0.56, which amounts to a dividend yield of 2.71%.
| Dividend Per Share | $0.56 |
| Dividend Yield | 2.71% |
| Dividend Growth (YoY) | 140% |
| Payout Ratio | -51.38% |
| Earnings Yield | 10.59% |
| FCF Yield | -8.04% |
Analyst Forecast
The average price target for THRD is $5, which is -2.9% lower than the current price. The consensus rating is "Hold".
| Price Target | $5 |
| Price Target Difference | -2.9% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
Scores
| Altman Z-Score | 14.53 |
| Piotroski F-Score | 2 |